NO178543C - Analogifremgangsmåte for fremstilling av terapeutisk aktive benzopyranderivater - Google Patents
Analogifremgangsmåte for fremstilling av terapeutisk aktive benzopyranderivaterInfo
- Publication number
- NO178543C NO178543C NO912344A NO912344A NO178543C NO 178543 C NO178543 C NO 178543C NO 912344 A NO912344 A NO 912344A NO 912344 A NO912344 A NO 912344A NO 178543 C NO178543 C NO 178543C
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- therapeutically active
- analogous process
- benzopyran derivatives
- active benzopyran
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/68—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with nitrogen atoms directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Quinoline Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54042390A | 1990-06-18 | 1990-06-18 |
Publications (4)
Publication Number | Publication Date |
---|---|
NO912344D0 NO912344D0 (no) | 1991-06-17 |
NO912344L NO912344L (no) | 1991-12-19 |
NO178543B NO178543B (no) | 1996-01-08 |
NO178543C true NO178543C (no) | 1996-04-17 |
Family
ID=24155395
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO912344A NO178543C (no) | 1990-06-18 | 1991-06-17 | Analogifremgangsmåte for fremstilling av terapeutisk aktive benzopyranderivater |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0462761A3 (no) |
JP (1) | JPH04243852A (no) |
KR (1) | KR920000742A (no) |
CN (1) | CN1057461A (no) |
AU (1) | AU651105B2 (no) |
CA (1) | CA2043281A1 (no) |
CS (1) | CS185291A3 (no) |
FI (1) | FI912931A (no) |
HU (1) | HU210924B (no) |
IE (1) | IE911948A1 (no) |
IL (1) | IL98239A0 (no) |
MX (1) | MX26184A (no) |
MY (1) | MY107474A (no) |
NO (1) | NO178543C (no) |
PL (3) | PL166787B1 (no) |
PT (1) | PT98019A (no) |
RU (1) | RU2059635C1 (no) |
TW (1) | TW230772B (no) |
ZA (1) | ZA913923B (no) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5453421A (en) * | 1992-09-11 | 1995-09-26 | E. R. Squibb & Sons, Inc. | Aryl and heterocyclic substituted propenamide derivatives |
US5374643A (en) * | 1992-09-11 | 1994-12-20 | E. R. Squibb & Sons, Inc. | Aryl urea (thiourea) and cyanoguanidine derivatives |
US5514690A (en) * | 1992-11-17 | 1996-05-07 | E. R. Squibb & Sons, Inc. | Aminocarbonyl (thiocarbonyl) and cyanoguanidine derivatives of quinoline and indoline |
IL109229A0 (en) * | 1993-05-11 | 1994-07-31 | Bristol Myers Squibb Co | Heterocyclic compounds and processes for the preparation of pyranyl cyanoguanidine derivatives using the same |
US5393771A (en) * | 1993-05-12 | 1995-02-28 | Brisol-Myers Squibb Company | 4-substituted benzopyran and related compounds |
TW310327B (no) * | 1993-06-18 | 1997-07-11 | Bristol Myers Squibb Co | |
US5612323A (en) * | 1995-06-07 | 1997-03-18 | Bristol-Myers Squibb Company | Phosphinic ester substituted benzopyran derivatives |
US5612370A (en) * | 1995-06-07 | 1997-03-18 | Bristol-Myers Squibb Company | Phenylglycine and phenylalaninen amido benzopyran derivatives |
US5629429A (en) * | 1995-06-07 | 1997-05-13 | Bristol-Myers Squibb Company | Process for preparing 4-arylamino-benzopyran and related compounds |
US5869478A (en) * | 1995-06-07 | 1999-02-09 | Bristol-Myers Squibb Company | Sulfonamido substituted benzopyran derivatives |
US6262269B1 (en) * | 1997-02-04 | 2001-07-17 | Trega Biosciences, Inc. | 4-Substituted-quinoline derivatives and 4-substituted-quinoline combinatorial libraries |
GB0028697D0 (en) * | 2000-11-23 | 2001-01-10 | S P A | Novel process |
EP1401823B1 (en) * | 2001-06-25 | 2005-10-05 | Nissan Chemical Industries, Ltd. | Substituted benzopyran derivatives against arrhythmia |
CN100503602C (zh) * | 2002-04-10 | 2009-06-24 | 东部韩农化学株式会社 | 用包括四唑的仲胺取代的苯并吡喃衍生物、其制备方法以及含有它们的药物组合物 |
KR100545780B1 (ko) * | 2003-05-28 | 2006-01-24 | 동부한농화학 주식회사 | 벤즈이미다졸 유도체로 치환된 벤조피란 유도체 또는약학적으로 허용되는 그의 염, 이의 제조 방법 및 이를포함하는 약학적 조성물 |
KR100512486B1 (ko) * | 2003-05-28 | 2005-09-06 | 동부한농화학 주식회사 | 싸이옥소벤즈옥사졸 유도체로 치환된 벤조피란 유도체또는 약학적으로 허용되는 염, 이의 제조방법 및 이를포함하는 약학적 조성물 |
WO2005014586A1 (en) * | 2003-08-08 | 2005-02-17 | Arpida Ag | Novel process for the preparation of 2h-chromenes |
EP1589015A1 (en) * | 2004-02-03 | 2005-10-26 | Université de Liège | Benzopyran derivatives, method of production and use thereof |
AP2008004432A0 (en) | 2005-10-07 | 2008-04-30 | Glenmark Pharmaceuticals Sa | Substituted benzofused derivatives and their use as vanilloid receptor ligands |
WO2009095726A1 (en) * | 2008-01-29 | 2009-08-06 | Glenmark Pharmaceuticals, S.A. | Acrylamide derivatives as vanilloid receptor 1 modulators |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3486354T2 (de) * | 1983-05-18 | 1995-03-30 | Beecham Group Plc | Chroman- und Chromenderivate. |
ES2058148T3 (es) * | 1987-02-04 | 1994-11-01 | Hoechst Ag | N-benzopiranil-lactamas sustituidas con alquilo, procedimiento para su preparacion, su empleo, asi como preparados farmaceuticos a base de estos compuestos. |
DE3901720A1 (de) * | 1989-01-21 | 1990-07-26 | Hoechst Ag | Substituierte benzo(b)pyrane, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen |
CA2015296C (en) * | 1989-05-31 | 2001-08-07 | Karnail Atwal | Pyranyl cyanoguanidine derivatives |
US5401848A (en) * | 1990-11-26 | 1995-03-28 | E. R. Squibb & Sons, Inc. | Indane and quinoline derivatives |
-
1991
- 1991-05-17 AU AU77102/91A patent/AU651105B2/en not_active Ceased
- 1991-05-18 MY MYPI91000841A patent/MY107474A/en unknown
- 1991-05-22 TW TW080104000A patent/TW230772B/zh active
- 1991-05-23 ZA ZA913923A patent/ZA913923B/xx unknown
- 1991-05-23 IL IL98239A patent/IL98239A0/xx unknown
- 1991-05-24 CA CA002043281A patent/CA2043281A1/en not_active Abandoned
- 1991-06-07 IE IE194891A patent/IE911948A1/en unknown
- 1991-06-11 MX MX2618491A patent/MX26184A/es unknown
- 1991-06-14 CN CN91104110A patent/CN1057461A/zh active Pending
- 1991-06-14 EP EP19910305398 patent/EP0462761A3/en not_active Ceased
- 1991-06-17 RU SU914895678A patent/RU2059635C1/ru active
- 1991-06-17 FI FI912931A patent/FI912931A/fi not_active Application Discontinuation
- 1991-06-17 HU HU912013A patent/HU210924B/hu not_active IP Right Cessation
- 1991-06-17 CS CS911852A patent/CS185291A3/cs unknown
- 1991-06-17 KR KR1019910009951A patent/KR920000742A/ko not_active Application Discontinuation
- 1991-06-17 NO NO912344A patent/NO178543C/no unknown
- 1991-06-18 PL PL91290720A patent/PL166787B1/pl unknown
- 1991-06-18 PL PL91303459A patent/PL166809B1/pl unknown
- 1991-06-18 JP JP3145778A patent/JPH04243852A/ja not_active Withdrawn
- 1991-06-18 PL PL91303457A patent/PL167832B1/pl unknown
- 1991-06-18 PT PT98019A patent/PT98019A/pt not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
FI912931A (fi) | 1991-12-19 |
PL166809B1 (pl) | 1995-06-30 |
HU210924B (en) | 1995-09-28 |
IL98239A0 (en) | 1992-06-21 |
NO912344L (no) | 1991-12-19 |
JPH04243852A (ja) | 1992-08-31 |
CN1057461A (zh) | 1992-01-01 |
ZA913923B (en) | 1992-02-26 |
EP0462761A3 (en) | 1992-01-22 |
MY107474A (en) | 1995-12-31 |
RU2059635C1 (ru) | 1996-05-10 |
EP0462761A2 (en) | 1991-12-27 |
MX26184A (es) | 1993-10-01 |
NO912344D0 (no) | 1991-06-17 |
KR920000742A (ko) | 1992-01-29 |
PL167832B1 (pl) | 1995-11-30 |
CA2043281A1 (en) | 1991-12-19 |
CS185291A3 (en) | 1992-04-15 |
TW230772B (no) | 1994-09-21 |
AU651105B2 (en) | 1994-07-14 |
NO178543B (no) | 1996-01-08 |
AU7710291A (en) | 1991-12-19 |
PT98019A (pt) | 1992-04-30 |
FI912931A0 (fi) | 1991-06-17 |
PL290720A1 (en) | 1992-03-23 |
HU912013D0 (en) | 1991-12-30 |
HUT58066A (en) | 1992-01-28 |
IE911948A1 (en) | 1991-12-18 |
PL166787B1 (pl) | 1995-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI96861C (fi) | Menetelmä terapeuttisesti aktiivisten substituoitujen indolyylipyrrolijohdannaisten valmistamiseksi | |
NO176759C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater | |
NO176319C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive furanderivater | |
NO178543C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive benzopyranderivater | |
NO174467C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater | |
NO179283C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte azoler | |
NO175478C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive diazepin-derivater | |
NO179584C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-acylaminotiazoler | |
NO179448C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive forbindelser | |
NO178498C (no) | Analogifremgangsmåte ved fremstilling av terapeutisk aktive karbapenemderivater | |
NO176275C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridazinonderivater | |
NO178068C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive tiazolidindionderivater | |
FI930723A0 (fi) | Menetelmä terapeuttisesti aktiivisten tiatsolidiinijohdannaisten valmistamiseksi | |
NO175528C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive fenylacetamid-derivater | |
NO173334C (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive alkylaminoalkylenderivater 2H-1-benzopyraner | |
FI884910A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten bentsopyraanijohdannaisten valmistamiseksi | |
NO174391C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater | |
NO173784C (no) | Anaslogifremgangsmaate for fremstilling av terapeutisk aktive tieno-tri-azolo-diazepinderivater | |
NO176477C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-alkoksymetylsubstituerte kromanderivater | |
NO174422C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater | |
NO178698C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive glycerolderivater | |
NO176100C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive oksodihydropyridyl- og oksodihydropyridazinylkromanderivater | |
NO176099C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-(2-okso-3-pyridyl)-kromanderivater | |
FI903077A0 (fi) | Menetelmä valmistaa terapeuttisesti aktiivisia R(-)-3-kinuklidinolijohdannaisia | |
NO174203C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive |